Pricing Log in Create free account

Rallybio Corporation (RLYB) vs vTv Therapeutics Inc. (VTVT)

Rallybio Corporation and vTv Therapeutics Inc. are both Biotechnology companies. Rallybio Corporation and vTv Therapeutics Inc. are of similar size ($86.0M and $84.5M). vTv Therapeutics Inc. has negative trailing earnings, so its P/E is not meaningful; Rallybio Corporation trades at 3.3×. vTv Therapeutics Inc. grew revenue faster over the last twelve months: 654.6% against 1.18%. Across the 13 metrics below, Rallybio Corporation leads on 10 and vTv Therapeutics Inc. on 3.

Valuation

Metric RLYB VTVT Biotechnology median
P/E 3.35 n/m 10.60
P/S 104.91 6.97 9.40
P/B 0.98 3.36 2.13
Price to free cash flow 2.91 n/m 25.18
EV/EBITDA 0.03 n/m 0.66
EV/Sales (0.79) 4.72 9.02
Earnings yield 29.85% (3.62%) (32.88%)
Free cash flow yield 34.39% (6.39%) (23.13%)

Profitability

Metric RLYB VTVT Biotechnology median
Gross margin 100.00% 99.92% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 34.52% (11.74%) (51.96%)
Return on assets 32.85% (8.34%) (46.06%)
Return on invested capital (944.36%) 0.00% 0.00%

Growth

Metric RLYB VTVT Biotechnology median
Revenue growth (TTM) 1.18% 654.58% 6.76%
EPS growth (last fiscal year) 85.06% 0.00% 29.88%
Revenue growth, 5-year CAGR — (39.39%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric RLYB VTVT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 28.87 12.48 4.97
Net debt to EBITDA 1.63 2.71 1.01

Dividend

Metric RLYB VTVT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric RLYB VTVT Biotechnology median
Market cap 84.47m 85.96m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack